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Abstract
Eating Disorders (EDs) show a multifactorial etiopathogenesis including environmental, psy-
chological and biological factors. In the present study, we propose a model of interactions
between genetic vulnerability—represented by Fat Mass and Obesity-Associated (FTO)
gene—and stable psychopathological traits, such as bodily disorders and emotion dysregu-
lation for EDs patients. The distribution of a polymorphism of the FTO (rs9939609 T>A) was
evaluated in a series of 250 EDs patients and in a group of 119 healthy control subjects.
Clinical data were collected through a face-to-face interview and several self-reported
questionnaires were applied, including the Emotional Eating Scale and the IDentity and
EAting disorders (IDEA) questionnaire for bodily disorders and self-identity. The A-allele
was associated with an increased vulnerability to EDs (AA+AT genotypes frequency
72.8% in EDs vs. 52.9% in controls). The presence of the A-allele was associated with
binge eating behavior, higher emotional eating and higher IDEA scores. Finally, the FTO
rs9939609 SNP was found to influence the relationship between these variables, as an
association between disorder of corporeality and emotional eating was found only in A-
allele carriers. A-allele seems to represent a potential additive risk factor for EDs persons,
with bodily disorders to develop emotional eating and binge eating behaviors.
Introduction
The multifactorial etiopathogenesis of eating disorders (EDs) encompasses environmental, psy-
chological and biological factors [1]. According to a gene-environmental approach, the different
expression of the psychopathological core can be influenced by genetic variability, explaining a
part of the variance of the susceptibility to EDs and different phenotypical features [2]. In this
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view, several genes have been investigated as possible candidates [3]. Among these, great inter-
est has been recently devoted to the Fat Mass and Obesity-Associated (FTO) gene, previously
implicated in obesity within several association studies [4,5], as a possible candidate for playing
a role in the pathogenesis of EDs [6]. FTO encodes for an AlkB-like 2-oxoglutarate–dependent
nucleic acid demethylase, a potential regulator of RNA modification, whose cellular function so
far remains undefined [7].
The molecular basis of the association between the FTO locus and obesity have been hypothe-
sized, even though the involved cell types and target genes remain uncharacterized [8]. Recently,
several authors evidenced, with state-of-the-art chromatin-capture sequencing technologies, that
noncoding variations in Single Nucleotide Polymorphisms (SNPs) within a 47-kb region in
introns 1 and 2 of FTO do no affect the expression of this gene, but are connected, at megabase
distances with the homeobox gene IRX3 in the human, mouse and zebrafish genomes [8,9]. IRX3
encodes a transcription factor expressed in multiple regions of the brain including cerebellum
and hypothalamus, suggesting that this gene plays an important role in the regulation of body
mass and composition [9].
In addition, Claussnitzer et al. [8] demonstrated that specific FTO variant can disrupt a
conserved motif for the ARID5B repressor, leading to derepression of a potent preadipocyte
enhancer and a doubling of IRX3 and IRX5 expression during early adipocyte differentiation.
Among FTO SNPs involved in this mechanism and associated with obesity, rs9939609 (located
82.431kb downstream of ATG start codon) is the most frequently described. The obesity predis-
posing risk A-allele is considered one of the strongest risk factor for polygenetic obesity in the
Caucasian ethnic group worldwide, showing carriers of this allele with a significantly higher BMI
and adiposity, as well as consuming a higher percentage of energy from fat [5, 10]. The interest in
the relationship between rs9939609 and EDs pathogenesis is also due to the role of this SNP in
satiety responsiveness [11] and to FTO high expression in the hypothalamic regions of the brain
associated with appetite regulation [12]. Notwithstanding the hypothetically relevant connection
between EDs, satiety and appetite regulation, conflicting results have so far been reported about
the possible associations between FTO and EDs. In fact, Mu¨ller et al. [6] found an association of
the A-allele with both diagnoses of Anorexia Nervosa (AN) and Bulimia Nervosa (BN), while
Jonassaint et al. [12] did not find any significant association with AN diagnosis. However, rs993
9609 was not evaluated in this latter study, which pointed at others FTO SNPs. Moreover, data
about Binge Eating Disorder (BED) are totally lacking. Thus, these spurious results do not rule
out a role of FTO in the susceptibility to EDs, suggesting that this association should be further
investigated using a more refined assessment of ED psychopathology. Also, phenotypes defined
by DSM diagnoses such as AN, BN, BED are known to be unstable through time [13, 14, 15] and
unsuitable for correlations with genetic polymorphisms.
Our hypothesis is that significant correlations can be found between FTO and ED pheno-
types associated with stable traits such as disorders of corporeality. Indeed, they have been
found to often precede eating disorders [16] and to predict long term outcome [14, 17]. In
this view, in the present study we propose a model of interactions between genetic vulnera-
bility represented by a specific polymorphism and stable psychopathological traits, resulting
in specific pathological eating attitudes and behavior, which can be considered as endophe-
notypes (intermediate phenotypes) of this condition. In particular, high-risk variant in FTO
could affect eating behaviours (i.e. by means of binge-eating episodes) and promote exces-
sive weight gain and obesity.
The main aim of the present study is to investigate the role of A-allele at rs9939609 as a risk
factor for Eating Disorder and in particular for the above mentioned specific ED psychopa-
thology aspects.
FTO gene and psychopathological traits in eating disorders
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Materials and methods
The distribution of the FTO rs9939609 (T>A) was evaluated in a series of 250 Italian, Cauca-
sian, EDs patients referred to the outpatient clinic for EDs at the Florence University School of
Medicine, and in a group of 119 Caucasian healthy sex matched control subjects. All diagnostic
procedures (apart from the extraction of blood samples and genetic analyses) and psychomet-
ric tests are part of the routine clinical assessment for EDs patients regularly performed at our
clinic, as previously described [18]. Study procedures were fully explained during the first rou-
tine visit and prior to the collection of data; after which the patients were asked to provide two
different written informed consents, one for participation in the clinical study and one for the
genetic analysis. The study protocol was performed in compliance with the Declaration of Hel-
sinki and was approved by the Ethics Committee of G. d’Annunzio University and Careggi
Hospital University, respectively. The detailed study design has already been described in two
earlier studies reported by our group [18, 19].
Participants
EDs patients attending the outpatient clinic for EDs of Florence, Italy, between July 2010 and
March 2014 were enrolled in the study, provided they met the following inclusion criteria: aged
between 18 and 60 years; current DSM-IV diagnosis of AN and BN assessed by means of the
Structured Clinical Interview for DSM-IV [20]. The study design and methodology was adopted
from our previous studies [18]. The diagnoses were based on the current symptomatology at refer-
ral. Patients were included if they reported at least 3 years of a stable diagnosis, according to the
Diagnostic and Statistical Manual of Mental Disorder Fourth Edition (DSM-IV) criteria [21]. The
Structured Clinical interview for DSM-IV was also used to identify the presence of comorbid axis
I mental disorders. Exclusion criteria were as follows: a BMI of<14 kg/m2, comorbid schizophre-
nia, bipolar I disorder, illiteracy, intellectual disability; severe medical conditions; current use of
psychoactive medications, with the exception of antidepressant medication and benzodiazepines.
Of the 273 subjects who met the participation criteria, 250 agreed to participate in the
study. In particular, 134 patients were affected by AN [56 with AN-B/P subtype (BP), 78 with
AN-restricting subtype (AN-R)] (mean age ± SD = 29.8 ± 10.3 years) and 116 by BN (mean
age ± SD = 30.7 ± 10.8 years). Patients were compared with a group of 119 Caucasian unrelated
controls (mean age ± SD = 24.4 ± 4.2 years), consecutively recruited through local advertise-
ments at the “G. d’Annunzio” University of Chieti-Pescara. The controls were carefully inter-
viewed in order to exclude any history of an ED, any actual psychiatric axis I disorder or the
presence of a first-degree relative suffering from an ED.
Study design
The study was based on a naturalistic approach. The clinical assessment, as well as the collec-
tion of blood samples, was conducted on the first day of admission.
Assessment
The clinical assessment is described more in depth in previous publications from our group [18,
19]. Socio-demographic, psychopathological, and clinical data were collected through a face-to-
face interview by two expert psychiatrists (G.C., V.R.). The ED diagnoses were performed using
the structured clinical interview for DSM-IV axis I disorders [20]. Eating attitudes and behav-
iors were specifically investigated by means of the Eating Disorder Examination Questionnaire
(EDE-Q) [22]. Emotional eating defined as “tendency to eating in response to different emo-
tions” was assessed by means of the Emotional Eating Scale (EES) [23].
FTO gene and psychopathological traits in eating disorders
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For further characterization of the psychopathological features of the patients, the Beck
Depression Inventory (BDI), a widely used and well established measure of current depression
level and symptoms [24], the Spielberg’s State-Trait Anxiety Inventory (STAI), to measure lev-
els of trait anxiety [25] and the IDentity and EAting disorders (IDEA) questionnaire [26] were
administered.
IDEA represents a multidimensional, brief, versatile, easy-to-perform self-reported instru-
ment for clinical evaluation, assessing bodily disorders, and of personal identity, specifically
associated with the core features of ED psychopathology. The questionnaire consists of 23
items evaluated by a likert scale from (0) “not at all” to (4) “very much”.
The questionnaire provided a total score and four subscales: ‘Feeling oneself only through
the gaze of the other and defining oneself only through the evaluation of the other’ (GEO),
‘feeling oneself only through objective measures’ (OM), feeling extraneous from one’s own
body’ (EB), and ‘feeling oneself only through starvation’ (S) [26]. Total IDEA scores were cal-
culated by averaging participants’ rating across the 23 items. The test showed good test-retest
reliability, and internal consistency, both in clinical [26] and general population [27].
The total score of the BDI (ranges from 0 to 63) and STAI (ranges from 20 to 80) were cal-
culated by summing up item scores. Instead, EDE-Q and EES total scores were calculated by
averaging participants’ rating, respectively.
Genetic analysis
Genomic DNA was isolated from peripheral blood lymphocytes of ED patients and buccal
swabs of controls using standard methods. All DNA samples were amplified by Polymerase
Chain Reaction (PCR) performed in 25 μl reaction volume containing 50 ng of genomic DNA
in a AB Applied Biosystem 2720 thermal cycler (Applied System, Foster City, CA), using the
KAPA Taq DNA polymerase (Resnova, Genzano, Italy). The amplification products was sub-
mitted to: i) direct sequencing procedure using BigDye Term v3.1 CycleSeq Kit (Life Technol-
ogies, Monza, Italy) followed by automatic sequencing analysis (ABI PRISM 3130XL) or ii)
High Resolution Melting (HRM) using PikoReal™ Real-Time PCR System (Thermo Scientific)
according to the manufacturer’s instructions.
Statistical analysis
Clinical variables. Continuous variables were reported as mean ± SD, whereas categorical
variables were reported as numbers and percentages. The independent sample t test and the χ2
were used for continuous and categorical variables respectively, to compare AN and BN groups.
Genotype analyses. A principle component analysis (PCA), with Varimax rotation, using
genotype as a qualitative variable was performed. PCA applied to genotype data can be used
to calculate principal components (PCs) that explain differences among the sample individuals
in the genetic data. Based on the presence of each genotype (AA, AT, and TT) for each subject
of the overall sample, the FTO SNP was transformed and coded into three binary variables
(0 = absence of genotype on each subject; 1 = presence of genotype on each subject) named:
AA, AT and TT variables.
According to Kaiser’s criterion [28], PCs with eigenvalues greater than 1 were extracted.
Component Plot in rotated space was also provided to a better visual representation of the
loadings plotted in a 2-dimensional space. Differences on each of the genotype components
indicated by the PCA between patients and healthy control subjects, as well as among AN and
BN subgroups and healthy control subjects, were tested using one-way analysis of variance. In
addition, correlation analysis among the genotype components indicated by the PCA, IDEA
and EES scores, and some socio-demographic variables (age and BMI) was performed.
FTO gene and psychopathological traits in eating disorders
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First of all, genetic analyses were performed considering AN and BN as separate groups, as
they may show different genetic components. Considering the well demonstrated instability of
DSM diagnostic categories, we further evaluated genotypes on the basis of behavioral and
psychopathological features.
The overall association between the ED (AN or BN) and the FTO genotypes (AA, AT, TT),
was tested. Considering the heterogeneity of the adopted models for this SNP in the scientific
literature, genotype analyses were performed assuming dominant (TT vs. TA+AA), co-domi-
nant (TT vs. AT vs. AA) and recessive (TT+TA vs. AA) models by means of the χ2 statistics.
We compared genotype distribution separately between ED and healthy controls. Indepen-
dent sample t test was performed to evaluate BMI, EDE-Q, total and subscale scores, EES, BDI,
and STAI, IDEA total and subscales scores differences in the patients with different FTO geno-
types. General Linear Models were adopted to test the moderating effects of FTO genotypes on
the association between IDEA scores and psychopathology. In particular, a first model was
tested with Emotional Eating total score as dependent variable (EDs psychopathology) and
age, BMI and IDEA scores as covariates. Then, in a second model, we entered IDEA by FTO
genotypes (AA, AT, TT) interaction. The Statistical Package for the Social Sciences for Win-
dows SPSS (IBM, 2011) version 20.0 was used for data analysis.
Results
The demographic and clinical characteristics of ED and control groups are reported in Table 1.
As expected, AN patients showed a lower BMI as compared with controls as well as with BN
Table 1. General, Psychopathological and Clinical Characteristics of the Eating Disorders groups.
AN (n: 134) BN (n: 116) Χ2; Independent sample t test Healthy controls (n: 119)
Age (years) 29.8 ± 10.3 30.7 ± 10.8 0.37 24.4 ± 4.2§§, ##
SEX (women) 126 (94.0%) 114 (98.3%) 2.91 119
BMI (kg/m2) 16.1 ± 1.5 21.2 ± 2.6 19.4 ** 22.2 ± 3.1§§
BDI 21 ± 11 21 ± 9 -0.19 -
STAI-S 39 ± 22 38 ± 24 0.15 -
STAI-T 45 ± 26 40 ± 26 0.82 -
EDE-Q total score 3.1 ± 1.3 3.0 ± 1.4 0.37 -
EDE-Q restraint 2.7 ± 1.5 2.7 ± 1.8 -0.31 -
EDE-Q eating concern 2.8 ± 1.4 2.6 ± 1.6 0.79 -
EDE-Q weight concern 3.3 ± 1.5 3.2 ± 1.7 0.35 -
EDE-Q shape concern 3.8 ± 1.5 3.6 ± 1.7 0.73 -
EES total score 1.6 ± 1.0 1.7 ± 1.1 -0.56 -
IDEA total score 1.5 ± 0.9 1.4 ± 0.9 1.31 0.8 ± 0.7§§, ##
IDEA GEO 1.5 ± 1.0 1.3 ± 1.1 1.67 0.8 ± 0.8§§, ##
IDEA OM 1.9 ± 1.2 1.8 ± 1.1 0.54 0.9 ± 1.0§§, ##
IDEA EB 1.5 ± 1.1 1.3 ± 1.1 1.05 0.5 ± 0.7§§, ##
IDEA S 1.3 ± 1.1 1.3 ± 1.1 0.04 1.2 ±0.9§§, ##
Statistics: Data are reported as numbers (percentage), and mean ± SD.
Abbreviations: AN, anorexia nervosa; BN, bulimia nervosa; BMI, body mass index; BDI, beck depression inventory; STAI, state/trait anxiety inventory;
EDE-Q, Eating Disorder Examination Questionnaire; EES: Emotional Eating Scale; IDEA: Identity and Eating Disorders Questionnaires; GEO: ‘feeling
oneself only through the gaze of the other and defining oneself only through the evaluation of the other’; OM: ‘feeling oneself only through objective
measures’; EB: ‘feeling extraneous from one’s own body’; S: ‘feeling oneself only through starvation’.
Comparisons between AN and BN patients—**P <0.01. Comparisons between healthy controls and AN patients - §§: p<0.01. Comparisons between
healthy controls and BN patients—##: p<0.01.
doi:10.1371/journal.pone.0173560.t001
FTO gene and psychopathological traits in eating disorders
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patients. Patients and controls did not differ in terms of education (mean years of education
12.5 ± 1.7 vs 12.8 ± 1.4; t = 1.7, p = 0.08). Other comparisons between clinical groups were not
significant.
By applying PCA, two orthogonal (not correlated) PC, with eigenvalues greater than 1, best
explained our genotypes sample structure. The rotated component matrix showed that the first
PC was composed by TT genotype variable, which accounted for 54% of the total variance (eigen-
value = 1.62). The second PC was identified by AA genotype variable, explaining 46% of the total
variance (eigenvalue = 1.38). Differently, the AT genotype variable showed double salient load-
ings on both the components, thus making it not interpretable [29]. Component Plot in rotated
space showed how closely related the variables were each other and to the two components. As
you can see in Fig 1, the two genotype variables were orthogonal: TT genotype variable showed
factor loadings close to 1 on the first component, and close to 0 on the second, while AA genotype
variable showed loadings close to 0 on the first component, and near 1 on the second. AT geno-
type variable had negative and moderate loadings on both the components, thus it resulted to be
not easily identifiable in the factor space. Thus, the factor solution that met best the criterion of
simple structure as defined by Thurstone [30, 31], in order to guarantee easy interpretability of
the extracted components and good replicability of the results, included two components: AA
and TT genotype components.
Significant difference (F1, 367 = 8.28, p< .01) on AA and TT genotype components between
patients and healthy control subjects was found.
Healthy control subjects (MTT = |.215| MAA = |.237| SDTT = 1.079, SDAA = .796) reported signif-
icantly higher means on AA and TT genotype components, compared to patients (MAA = |.102|,
MTT = |.113|; SDTT = .945, SDAA = 1.066). Also, significant differences on TT (F2, 368 = 4,21, p<
.05) and AA (F2, 368 = 9,99, p< .001) genotype components between AN subgroup, BN subgroup
and healthy control subjects were found. Specifically, on TT genotype component, the Bonferroni
post-hoc revealed that healthy control subjects showed significantly higher mean (M = |.21|, SD =
|1.07|) compared to AN subgroup (M = |.12|, SD = |.98|), while no significant differences between
Fig 1. Component Plot in Rotated Space.
doi:10.1371/journal.pone.0173560.g001
FTO gene and psychopathological traits in eating disorders
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BN subgroup mean (M = |.07|, SD = |.89|) versus AN group mean and versus healthy control sub-
jects were found. As regards AA genotype component, BN subgroup showed significantly higher
mean (M = |.32|, SD = |1.14|) compared to AN subgroup (M = |.06|, SD = |.97|) and healthy control
subjects (M = |.24|, SD = |.80|).
Summing up, the PCA best explained differences among the sample individuals in the
genotype data.
Also, correlations of the two genotype components with IDEA and EES scores, as well as
with socio-demographic variables (age and BMI), were tested. Results showed that TT geno-
type component correlated significantly with IDEA EB (r = -.03, p>.01), while AA genotype
component correlated significantly with IDEA GEO (r = .12, p>.05), IDEA EB (r = .11,
p>.05), and EES total score (r = .12, p>.05).
The distribution of genotypes of rs9939609 in controls and EDs patients as a whole sample
and according to different categories (AN, BN) are reported in Table 2. A significant difference
was detected in terms of genotype distribution between healthy controls and ED patients,
being A-allele carriers (AA and AT genotypes) significantly more frequent in EDs patients
than in healthy controls (72.8% vs 52.9%, Χ2 = 14.2; p<0.001).
Odds ratio with 95% CIs were used for dominant model (AA + AT vs. TT) in ED subjects
versus control subjects (OR: 2.37; 95% CI: 1.50–3.75; P = 0.0002).
On the other hand, recessive model showed that AA genotype allele (AT + TT vs AA) was
more frequent in patients as compared with healthy controls (χ2 = 10.9; p = 0.001; OR 95%
CI = 2.65; 1. 46–4.80).
Within the ED patient group, no significant differences in the frequency of the A-allele
were detected between AN and BN (72.4% vs. 73.1%), while recessive model showed a signifi-
cant positive association of AA genotype with BN (χ2 = 6.48; p = 0.011; OR 95% CI = 2.0;
1.17–3.55).
A modest association was found between A-allele and binge eating behaviors (BN and AN
binge/purge patients), being A-allele carriers more frequent among these patients as compared
to ANR patients (76.7% vs. 64.1%, Χ2 = 4.31; p = 0.037). A modest association was found in
Table 2. Distribution of rs9939609 genotypes according to diagnoses, along with relative odds ratios.
GENETIC MODEL
CO-DOMINANT MODEL DOMINANT MODEL RECESSIVE MODEL
Groups No. Genotype n (%) Genotype n (%) Genotype n (%)
AA AT TT AA +AT (coded as 1) TT (coded as 0) AA (coded as 1) AT + TT (coded as 0)
Healthy controls 119 16 (13.4%) 47 (39.5%) 56 (47.1%) 63 (52.9%) 56 (47.1%) 16 (13.4%) 103 (86,6%)
EDs 250 73 (29.2%) 109 (43.6%) 68 (27.2%) 182 (72.8%) 68 (27.2%) 73 (29.2%) 177 (70,8%)
OR (CI) P χ2 = 18.08; p<0.001 χ2 = 14.2; p<0.001; OR 95% CI = 2.37;
1.50–3.75
χ2 = 10.9; p = 0.001;OR 95% CI = 2.65;
1.46–4.80
BN 116 43 (37.1%) 41 (35.3%) 32 (27.6%) 84 (72.4%) 32 (27.6%) 43 (37.1%) 73 (62,9%)
AN 134 30 (22.4%) 68 (50.7%) 36 (26.9%) 98 (73.1%) 36 (26.9%) 30 (22.4%) 104 (77,6%)
OR (CI) P Ns χ2 = 0.02; p = 0.98; OR 95% CI = 1.03;
0.59–1.81
χ2 = 6.48; p = 0.01; OR 95% CI = 2.04;
1.17–3.55
Binge eating patients 172 58 (33.7%) 74 (43.0%) 40 (23.3%) 132 (76.7%) 40 (23.3%) 58 (33.7%) 114 (66,3%)
AN restricter 78 15 (19.2%) 35 (44.9%) 28 (35.9%) 50 (64.1%) 28 (35.9%) 15 (19.2%) 63 (80,8%)
OR (CI) P χ2 = 7.05; p = 0.02 χ2 = 4.33; p = 0.037; OR 95% CI = 1.84;
1.03–3.30
χ2 = 5.45; p = 0.020; OR 95% CI = 2.13;
1.12–4.07
Legend: Binge eating patients include Bulimia Nervosa and Anorexia Nervosa binge/purge patients. ns: Not statistical significant.
Abbreviations: EDs: Eating Disorders; AN: Anorexia Nervosa; BN: Bulimia Nervosa.
doi:10.1371/journal.pone.0173560.t002
FTO gene and psychopathological traits in eating disorders
PLOS ONE | DOI:10.1371/journal.pone.0173560 March 10, 2017 7 / 14
recessive model between AA genotype and binge eating behaviors (χ2 = 5.45; p = 0.02; OR
95% CI = 2.13; 1.12–4.07).
In the controls, the FTO rs9939609 genotypic frequency did not deviate from Hardy-Wein-
berg equilibrium (HWE) (p = 0.23), whereas a marginal deviation was found in EDs
(p = 0.04).
The comparison of clinical variables, in relation to rs9939609 polymorphism, are reported
in Table 3. A-allele carriers, as compared to TT genotype carriers, reported significantly higher
emotional eating scores (1.7±1.0 vs. 1.3±1.0, χ2 = -2.65; p<0.01) and IDEA subscale scores, in
particular: ‘feeling oneself only through objective measures’ (2.1 ± 1.0 vs. 1.7 ± 1.2, χ2 = -1.96;
p<0.05) and ‘feeling extraneous from one’s own body’ (1.7 ± 1.2 vs. 1.2 ± 1.0, χ2 = -1.29;
p<0.05).
Finally, General Linear Model showed that FTO genotypes significantly moderated the
association between emotional eating and IDEA scores (Fig 2). A significant effect was added
entering FTO genotype in the model of association between Emotional Eating total score and
IDEA TS (R squared from = 0.04 to 0.09), and IDEA EB (R squared from = 0.13 to 0.18). In
particular, the models showed an increasing effect for the interaction according to different
genotypes (IDEA TS, AA: p<0.001, AT: p = 0.03, TT: p = 0.87; IDEA EB: AA: p<0.001, AT:
p = 0.001, TT: p = 0.21).
Discussion
In the present study, we evaluated the FTO rs9939609 variant as a risk factor for EDs, because
of its well-known role in controlling energy homeostasis and eating behavior [32]. To the best
Table 3. Comparison of clinical variables according to FTO genotypes.
A-allele carriers (AA and AT genotypes; n: 182) TT genotype (n: 68) Χ2; Independent sample t test
SEX (women) 182 (97.1%) 68 (95.6%) 0.27
BMI (kg/m2) 19.0 ± 4.0 18.7 ± 3.3 0.51
BDI 21 ± 11 23 ± 7 0.77
STAI-S 38 ± 24 38 ± 22 - 0.01
STAI-T 42 ± 26 43 ± 25 0.09
EDE-Q total score 3.1 ± 1.4 2.8 ± 1.2 - 1.21
EDE-Q restraint 2.7 ± 1.7 2.7 ± 1.3 0.02
EDE-Q eating concern 2.7 ± 1.5 2.5 ± 1.4 - 0.83
EDE-Q weight concern 3.3 ± 1.7 2.9 ± 1.4 - 1.38
EDE-Q shape concern 3.7 ± 1.7 3.4 ± 1.7 - 1.03
EES total score 1.7 ± 1.0 1.3 ± 1.0 - 2.65**
IDEA total score 1.4 ± 0.9 1.5 ± 0.8 0.49
IDEA GEO 1.4 ± 1.1 1.4 ± 1.0 0.11
IDEA OM 2.1 ± 1.0 1.7 ± 1.2 -1.96*
IDEA EB 1.7 ± 1.2 1.2 ± 1.0 -1.29*
IDEA S 1.3 ± 1.1 1.3 ± 1.0 -0.15
Statistics: Data are reported as numbers (percentage), and mean ± SD.
Abbreviations: AN, anorexia nervosa; BN, bulimia nervosa; BMI, body mass index; BDI, beck depression inventory; STAI, State/Trait anxiety inventory;
EDE-Q, Eating Disorder Examination Questionnaire; EES: Emotional Eating Scale; IDEA: Identity and Eating Disorders Questionnaires; GEO: ‘feeling
oneself only through the gaze of the other and defining oneself only through the evaluation of the other’; OM: ‘feeling oneself only through objective
measures’; EB: ‘feeling extraneous from one’s own body’; S: ‘feeling oneself only through starvation’.
*P <0.05.
**P <0.01.
doi:10.1371/journal.pone.0173560.t003
FTO gene and psychopathological traits in eating disorders
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of our knowledge, this is one of the very few studies considering the possible role of FTO in the
different expression of EDs specific psychopathology [6, 12]. In general, our preliminary study
showed that
FTO rs9939609 variant represents a putative risk factor for people with high disorder of
bodily disorders to develop emotional eating. As extensively reported in the literature, emo-
tional eating is a pathological behavior, which accounts for development of obesity and for sev-
eral pathological eating behaviors such as binge eating [33, 34].
As a first result, in both dominant and recessive models, we found a significant association
of rs9939609 A-allele with vulnerability to EDs, being this allele more frequent among EDs
patients than in controls. In particular, this association was related to the binge eating behav-
ior, present in both AN B/P and BN patients, rather than to the DSM diagnostic category.
Secondly, the A-allele was associated with an increased severity of specific EDs psychopath-
ological features, including emotional eating and disorder of corporeality, and it shows a mod-
erating effect between these variables. Many studies have analysed the FTO variants role on
metabolism, but only few studies have explored the association between FTO variants and
cerebral activity. Two groups explored how FTO’s putative demethylase action affect complex
human phenotypes [35, 36]. Karra et al. [36], using MRI techniques, demonstrated that FTO
genotype modulates the neural responses to food cues and modifies the responsivity to ghrelin
levels in the fasted state in normal-weight volunteers. These findings provide a possible expla-
nation to the link between the A-risk allele and obesity predisposition through the regulation
of the reward and appetite regions. Hess et al. [35] demonstrated the tissue- or even cell-type-
specific role of FTO by regulating mRNA subsets relevant to the physiological function of the
Fig 2. Relationship between IDEA scores and Emotional Eating in Eating Disorders patients (n: 250): moderating effect of FTO
genotypes. Statistics: Tables report General Linear Models FTO by IDEA interaction. The first models tested the effects of IDEA scores on
Emotional Eating, entering age, and BMI. In the second step FTO genotype interaction was added. Tables showed the increasing effect of
different FTO genotypes (AA, AT, TT).
doi:10.1371/journal.pone.0173560.g002
FTO gene and psychopathological traits in eating disorders
PLOS ONE | DOI:10.1371/journal.pone.0173560 March 10, 2017 9 / 14
tissue. This study described a potential role of FTO to influence food intake by altering D2
receptor-dependent feeding behaviour [35].
In a behavioral and fMRI study, Sevgi et al. [37] demonstrated that variants of the FTO gene
affect dopamine (D2)-dependent mesocorticolimbic-prefrontal responses that may influence
reward learning and behavioral responses associated with learning from negative outcome in
humans. In addition, Olivo et al. [38] studied the interaction between genetics, neural patterns,
and behavioral measures in determining the obesity risk. The authors suggested that the AA
carriers show neural connectivity patterns that might more closely influence the sensitivity
toward punishment and reward. In turn, social and environmental factors acting on this neu-
ral substrate might increase the susceptibility to obesity.
Moreover, a recent study demonstrated how AA and TT genotype are associated with dif-
ferential neural processing of food images of different caloric content: in fact, the AA genotype
had increased brain activity specifically in areas important for emotion (cingulate gyrus),
memory, and self-image (cuneus and precuneus) and reward (putamen) compared with the
TT genotype [39].
Different mechanisms for explaining FTO’s role in the association with ED susceptibility
can be proposed. A possible role in energy homeostasis is supported by studies performed on
humans, mice and rodents that have suggested that FTO non coding variants could affect
hypothalamic mRNA expression, in turn able to regulate food intake, circulating glucose lev-
els, weight status and energy expenditure [7, 40].
Despite all these emerging data, a study by Smemo et al. [9] pursued functional interactions
between obesity-linked SNPs and neighbouring genes. In fact, the authors demonstrated, for
the first time, an association between intronic variance within FTO and IRX3 expression, sug-
gesting a broader role for FTO beyond that of regulating fat mass [9]. The promoter of IRX3
directly binds to an enhancer sequence within the first FTO intron. The IRX3 role in the regu-
lation of body mass and composition is shown by a reduction in body weight of 25 to 30% in
Irx3-deficient mice, through increase in basal metabolic rate with browning of white adipose
tissue. In addition, hypothalamus-specific dominant-negative form of Irx3 mice reproduces
the metabolic phenotype of Irx3-deficient mice [9].
Therefore, FTO variants may represent a risk factor for overweight condition, in turn con-
sidered a frequent antecedent of both AN and BN patients [22]. Accordingly, previous studies
indicated an association of the rs9939609 risk A-allele with increased energy intake and
decreased satiety [11]. According to Mu¨ller et al., [6], it can be suggested that the observed
association of FTO with EDs might be independent from the elevating effect of this variant on
BMI, and that both a weight-elevating effect of the risk A-allele and a modulation of eating
behavior and satiety accounts for the observed associations.
The association of the A-allele at rs9939609 with AN was already observed by Muller et al.
[6]. Furthermore, Boraska et al. [41] performed a genome-wide association scan (GWAS) of
anorexia nervosa. When the authors compared 76 variants (53 independent) from the AN
results with 89 established BMI/obesity SNPs, FTO variant and other 4 SNPs (inside other
genes) had P<0.05 (binomial P = 0.1906). Twenty-six of the 53 SNPs had the same direction
of effect in AN and BMI/obesity (binomial P = 1) and 3 variants included FTO had P<0.05
(binomial P value = 0.0084), indicating modest enrichment of nominally associated SNP from
extreme obesity in their discovery dataset [41]. More recently, through cross-trait analysis of
the 1000 SNPs and functional ex vivo studies, Hinney et al [42] identified three genetic loci
involved in both anorexia nervosa risk and variation of BMI. None of the nine SNPs located in
these loci have previously been associated to either AN or BMI/obesity or other psychiatric dis-
orders. However, no SNPs in FTO gene reached genome-wide significance in data.
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Of particular interest is the association between the A-allele and the endophenotypes of
EDs. Interest in endophenotypes has been stimulated by the difficulties encountered in estab-
lishing specific genetic causes for complex disorders by classical linkage or association designs.
In this context, the concept of endophenotype may be of relevant value in order to bridge the
gap between the genotype and the phenotype, through the deconstruction of the clinical phe-
notype into variables hypothetically more proximal to genetic effects.
In this view, we attempted to overcome the behavioral level of the EDs psychopathology,
characterized by diagnostic instability [14, 43], by considering more stable quantitative traits,
such as emotional eating and disorders of corporeality, as candidate phenotypes relevant to
EDs pathology [44, 45].
Emotional Eating (EE)–defined as tendency to eat in response to a range of negative emo-
tions such as anxiety, depression, anger and loneliness, to cope with negative affect—has been
identified as a possible factor triggering binge eating in BN [23, 46] and binge eating disorder
[47]. A second candidate endophenotype for EDs investigated in this study was represented
by the bodily disorders [26, 27, 48]. Pathological concerns about body shape and weight are
considered as secondary epiphenomena to a more profound pathological core [17, 43]. ED
patients complain about their being alienated from their own body and emotions, and experi-
ence body as an object that is looked at and judged by other subjects [26]. Especially, feeling
extraneous from one’s own body may feature as a possible factor for abnormal eating patterns
via emotional dysregulation and/or the dysregulation of bodily-mediated satiety responsive-
ness. According to this model, the cenesthetic apprehension of one’s own body is the more
primitive and basic form of self-awareness, and patients with EDs often report–with different
extents of insight–their difficulties in perceiving their emotions and that they do not “feel”
themselves [27]. In this study, we found a significant association between emotional eating
and the IDEA subscale measuring feeling extraneous from one’s own body. Moreover, we
found that the A-allele of the rs9939609 represented a moderator of the association between
emotional eating and disorder of corporeality and identity measured by IDEA. Therefore, our
findings suggest bodily disorders in the individuals with the A-allele, is more likely to favor
emotional eating as well as binge eating phenomena.
Overall, the results confirm the importance of a fine-tuned characterization of the EDs psy-
chopathology based on qualitative and subjective rather than quantitative measures.
However, the present study has the limitation of the sample pool size being relatively small.
Future studies with a larger sample size are required. It should be noted that due to our small
sample size, we possibly overestimated the odds ratio of the minor allele.
Finally, the information regarding the population of patients seeking treatment cannot be
generalized to all people presenting pathological eating behaviors. It is possible that some
aspects of the described clinical features are state-dependent. However, it is important to note
that recent observations in clinical [14, 17] and general population [27] confirmed that disor-
ders of corporeality related with EDs are more stable across time as compared to DSM diagno-
ses, which are typically prone to the so called diagnostic crossover [13]. Indeed, the clear
association of FTO genotypes with measures of disorders of corporeality rather than with
DSM diagnoses confirmed the hypothesis that they can represent stable trait of EDs. In addi-
tion, the SNP diverts from equilibrium of these subjects: this would be consistent with the
association results of binge eating traits.
Furthermore, it should be remembered that the patients were included if they reported at
least 3 years of a stable diagnosis. This may explain in part the lack of age matching in between
cases and controls (there were significantly younger in the control group).
FTO gene and psychopathological traits in eating disorders
PLOS ONE | DOI:10.1371/journal.pone.0173560 March 10, 2017 11 / 14
Author Contributions
Conceptualization: LS GS VR.
Data curation: MF GC MM.
Formal analysis: GC MF.
Funding acquisition: LS.
Investigation: MF SB.
Methodology: VR LS GS.
Project administration: LS GS.
Resources: IA.
Software: GC MB.
Supervision: LS GS VR.
Validation: SS.
Visualization: IA BN LL.
Writing – original draft: GC MF.
Writing – review & editing: GC MF LS.
References
1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th edition.
Washington, DC: American Psychiatric Association; 2013.
2. Steiger H, Richardson J, Schmitz N, Joober R, Israel M, Bruce KR, et al. Association of trait-defined,
eating-disorder sub-phenotypes with (biallelic and triallelic) 5HTTLPR variations. J Psychiatr Res.
2009; 43:1086–94. doi: 10.1016/j.jpsychires.2009.03.009 PMID: 19383563
3. Hinney A, Volckmar AL. Genetics of eating disorders. Curr Psychiatry Rep. 2013; 15:423. doi: 10.1007/
s11920-013-0423-y PMID: 24202964
4. Hunt SC, Stone S, Xin Y, Scherer CA, Magness CL, Ladonato SP, et al. Association of the FTO gene
with BMI. Obesity (Silver Spring). 2008; 16: 902–904.
5. Peng S, Zhu Y, Xu F, Ren X, Li X, Lai M. FTO gene polymorphisms and obesity risk: a meta-analysis.
BMC Med. 2011; 9:71. doi: 10.1186/1741-7015-9-71 PMID: 21651756
6. Mu¨ller TD, Greene BH, Bellodi L, Cavallini MC, Cellini E, Di Bella D, et al. Fat mass and obesity-associ-
ated gene (FTO) in eating disorders: evidence for association of the rs9939609 obesity risk allele with
bulimia nervosa and anorexia nervosa. Obes Facts. 2012; 5:408–19. doi: 10.1159/000340057 PMID:
22797368
7. Gerken T, Girard CA, Tung YC, Webby CJ, Saudek V, Hewitson KS, et al. The obesity-associated FTO
gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science. 2007; 318:1469–1472.
doi: 10.1126/science.1151710 PMID: 17991826
8. Claussnitzer M, Dankel SN, Quon G, Meuleman W, Haugen C, Glunk V et al. FTO Obesity Variant Cir-
cuitry and Adipocyte Browning in Humans. N Engl J Med. 2015; 373:895–907. doi: 10.1056/
NEJMoa1502214 PMID: 26287746
9. Smemo S, Tena JJ, Kim KH, Gamazon ER, Sakabe NJ, Go´mez-Marı´n C et al. Obesity-associated vari-
ants within FTO form long-range functional connections with IRX3. Nature. 2014; 507:371–5. doi: 10.
1038/nature13138 PMID: 24646999
10. Tanofsky-Kraff M, Han JC, Anandalingam K, Shomaker LB, Columbo KM, Wolkoff LE, et al. The FTO
gene rs9939609 obesity-risk allele and loss of control over eating. Am J Clin Nutr. 2009; 90:1483–8.
doi: 10.3945/ajcn.2009.28439 PMID: 19828706
11. Wardle J, Carnell S, Haworth CM, Farooqi IS, O’Rahilly S, Plomin R. Obesity associated genetic varia-
tion in FTO is associated with diminished satiety. J Clin Endocrinol Metab. 2008; 93:3640–3643. doi:
10.1210/jc.2008-0472 PMID: 18583465
FTO gene and psychopathological traits in eating disorders
PLOS ONE | DOI:10.1371/journal.pone.0173560 March 10, 2017 12 / 14
12. Jonassaint CR, Szatkiewicz JP, Bulik CM, Thornton LM, Bloss C, Berrettini WH, et al. Absence of asso-
ciation between specific common variants of the obesity-related FTO gene and psychological and
behavioral eating disorder phenotypes. Am J Med Genet B Neuropsychiatr Genet. 2011; 156B: 454–
61. doi: 10.1002/ajmg.b.31182 PMID: 21438147
13. Tozzi F, Thornton LM, Klump KL, Fichter MM, Halmi KA, Kaplan AS et al. Symptom fluctuation in eating
disorders: correlates of diagnostic crossover. Am J Psychiatry. 2005; 162:732–40. doi: 10.1176/appi.
ajp.162.4.732 PMID: 15800146
14. Castellini G, Lo Sauro C, Mannucci E, Ravaldi C, Rotella CM, Faravelli C, Ricca V. Diagnostic crossover
and outcome predictors in eating disorders according to DSM-IV and DSM-V proposed criteria: a 6-year
follow-up study. Psychosom Med. 2011; 73:3270–9.
15. Milos GF, Baur V, Muehlebach S, Spindler A. Axis-I comorbidity is linked to prospective instability of
diagnoses within eating disorders. BMC Psychiatry. 2013; 7:295.
16. Fairburn CG, Harrison PJ. Eating disorders. Lancet. 2003; 361:407–16. doi: 10.1016/S0140-6736(03)
12378-1 PMID: 12573387
17. Bardone-Cone AM, Harney MB, Maldonado CR, Lawson MA, Robinson DP, Smith R, Tosh A. Defining
recovery from an eating disorder: Conceptualization, validation, and examination of psychosocial func-
tioning and psychiatric comorbidity. Behav Res Ther. 2010; 48: 194–202. doi: 10.1016/j.brat.2009.11.
001 PMID: 19945094
18. Castellini G, Ricca V, Lelli L, Bagnoli S, Lucenteforte E, Faravelli C et al. Association between serotonin
transporter gene polymorphism and eating disorders outcome: a 6-year follow-up study. Am J Med
Genet B Neuropsychiatr Genet. 2012; 159B: 491–500. doi: 10.1002/ajmg.b.32052 PMID: 22488946
19. Cellini E, Castellini G, Ricca V, Bagnoli S, Tedde A, Rotella CM, et al. Glucocorticoid receptor gene
polymorphisms in Italian patients with eating disorders and obesity. Psychiatr Genet. 2010; 20:282–8.
doi: 10.1097/YPG.0b013e32833a2142 PMID: 20440229
20. First MB, Spitzer MB, Gibbon M, Williams JBW. Structured clinical interview for DSM-IV Axis I disorders
patient edition (SCID-I/P version 2.0), New York: Biometrics Research Department, New York State
Psychiatric Institute; 1995.
21. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, fourth ed.
(revised). Washington, DC: American Psychiatric Association; 1994.
22. Fairburn CG, Beglin SJ. Assessment of eating disorders: interview or self-report questionnaire? Int J
Eat Disord. 1994; 16:363–70. PMID: 7866415
23. Arnow B, Kenardy J, Agras WS. The Emotional Eating Scale: the development of a measure to assess
coping with negative affect by eating. Int J Eat Disord. 1995; 18:79–90. PMID: 7670446
24. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch
Gen Psychiatry. 1961; 4:561–71. PMID: 13688369
25. Spielberg CD, Gorsuch RL, Lushene RE. Manual for the state-trait anxiety inventory (self-evaluation
questionnaire), Palo Alto, CA: Consulting Psychologists Press. 1970.
26. Stanghellini G, Castellini G, Brogna P, Faravelli C, Ricca V. Identity and eating disorders (IDEA): a
questionnaire evaluating identity and embodiment in eating disorder patients. Psychopathology. 2012;
45:147–58. doi: 10.1159/000330258 PMID: 22398386
27. Stanghellini G, Trisolini F, Castellini G, Ambrosini A, Faravelli C, Ricca V. Is feeling extraneous from
one’s own body a core vulnerability feature in eating disorders? Psychopathology. 2015; 48:18–24. doi:
10.1159/000364882 PMID: 25341960
28. Kaiser H.F. The application of electronic computers to factor analysis. Educational and Psychological
Measurement. 1960; 20: 141–151.
29. Kline P. An easy guide to factor analysis. New York, NY: Routledge 1994.
30. Thurstone L.L. Multiple-factor analysis. Chicago: Univ. Chicago Press 1947.
31. Cattell R.B. The scientific use of factor analysis in behavioral and life sciences. New York: Plenum
1978.
32. Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, Lindgren CM, et al. A common variant
in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity.
Science. 2007; 316: 889–894. doi: 10.1126/science.1141634 PMID: 17434869
33. Ricca V, Castellini G, Lo Sauro C, Ravaldi C, Lapi F, Mannucci E, Rotella CM, Faravelli C. Correlations
between binge eating and emotional eating in a sample of overweight subjects. Appetite. 2009; 53:
418–21. doi: 10.1016/j.appet.2009.07.008 PMID: 19619594
34. Fioravanti G, Castellini G, Lo Sauro C, Ianni S, Montanelli L, Rotella F, Faravelli C, Ricca V. Course and
moderators of emotional eating in anorectic and bulimic patients: a follow-up study. Eat Behav. 2014;
15:192–6. doi: 10.1016/j.eatbeh.2014.01.006 PMID: 24854803
FTO gene and psychopathological traits in eating disorders
PLOS ONE | DOI:10.1371/journal.pone.0173560 March 10, 2017 13 / 14
35. Hess ME, Hess S, Meyer KD, Verhagen LA, Koch L, Bro¨nneke HS, et al. The fat mass and obesity
associated gene (Fto) regulates activity of the dopaminergic midbrain circuitry. Nat. Neurosci. 2013;
16: 1042–1048. doi: 10.1038/nn.3449 PMID: 23817550
36. Karra E, O’Daly OG, Choudhury AI, Yousseif A, Millership S, Neary MT, et al. A link between FTO, ghre-
lin, and impaired brain food-cue responsivity. J Clin Invest. 2013; 123:3539–51. doi: 10.1172/JCI44403
PMID: 23867619
37. Sevgi M, Rigoux L, Ku¨hn AB, Mauer J, Schilbach L, Hess ME, et al. An Obesity-Predisposing Variant of
the FTO Gene Regulates D2R-Dependent Reward Learning. J Neurosci. 2015; 35:12584–92.
38. Olivo G, Wiemerslage L, Nilsson EK, Solstrand Dahlberg L, Larsen AL, Olaya Bu´caro M, et al. Resting-
State Brain and the FTO Obesity Risk Allele: Default Mode, Sensorimotor, and Salience Network Con-
nectivity Underlying Different Somatosensory Integration and Reward Processing between Genotypes.
Front Hum Neurosci. 2016; 10:52. doi: 10.3389/fnhum.2016.00052 PMID: 26924971
39. Wiemerslage L, Nilsson EK, Solstrand Dahlberg L, Ence-Eriksson F, Castillo S, Larsen AL, Bylund SB,
et al. An obesity-associated risk allele within the FTO gene affects human brain activity for areas impor-
tant for emotion, impulse control and reward in response to food images. Eur J Neurosci. 2016;
43:1173–80. doi: 10.1111/ejn.13177 PMID: 26797854
40. Poritsanos NJ, Lew PS, Fischer J, Mobbs CV, Nagy JI, Wong D, et al. Impaired hypothalamic Fto
expression in response to fasting and glucose in obese mice. Nutr. Diabetes. 2011; 1:e19. doi: 10.
1038/nutd.2011.15 PMID: 23154321
41. Boraska V, Franklin CS, Floyd JA, Thornton LM, Huckins LM, Southam L, Rayner NW, Tachmazidou I,
Klump KL, Treasure J et al. A genome-wide association study of anorexia nervosa. Mol Psychiatry.
2014; 19:1085–94. doi: 10.1038/mp.2013.187 PMID: 24514567
42. Hinney A, Kesselmeier M, Jall S, Volckmar AL, Fo¨cker M, Antel J, et al. Evidence for three genetic loci
involved in both anorexia nervosa risk and variation of body mass index. Mol Psychiatry. 2016.
43. Peterson CB, Crow SJ, Swanson SA, Crosby RD, Wonderlich SA, Mitchell JE, et al. Examining the sta-
bility of DSM-IV and empirically derived eating disorder classification: implications for DSM-5. J Consult
Clin Psychol. 2011; 79:777–783. doi: 10.1037/a0025941 PMID: 22040286
44. Keski-Rahkonen A, Neale BM, Bulik CM, Pietila¨inen KH, Rose RJ, Kaprio J, Rissanen A. Intentional
weight loss in young adults: sex-specific genetic and environmental effects. Obes Res. 2005; 13:745–
53. doi: 10.1038/oby.2005.84 PMID: 15897484
45. Wade TD, Bulik CM. Shared genetic and environmental risk factors between undue influence of body
shape and weight on self-evaluation and dimensions of perfectionism. Psychol Med. 2007; 37:635–44.
doi: 10.1017/S0033291706009603 PMID: 17176504
46. Castellini G, Mannucci E, Lo Sauro C, Benni L, Lazzeretti L, Ravaldi C, et al. Different moderators of
cognitive-behavioral therapy on subjective and objective binge eating in bulimia nervosa and binge eat-
ing disorder: a three-year follow-up study. Psychother Psychosom. 2012; 81:11–20. doi: 10.1159/
000329358 PMID: 22116257
47. Mond JM, Peterson CB, Hay PJ. Prior use of extreme weight-control behaviors in a community sample
of women with binge eating disorder or subthreshold binge eating disorder: a descriptive study. Int J Eat
Disord. 2010; 43:440–6. doi: 10.1002/eat.20707 PMID: 19551718
48. Castellini G, Stanghellini G, Godini L, Lucchese M, Trisolini F, Ricca V. Abnormal Bodily Experiences
Mediate the Relationship between Impulsivity and Binge Eating in Overweight Subjects Seeking Bariat-
ric Surgery. Psychother Psychosom. 2015; 84:124–126. doi: 10.1159/000365765 PMID: 25720444
FTO gene and psychopathological traits in eating disorders
PLOS ONE | DOI:10.1371/journal.pone.0173560 March 10, 2017 14 / 14
